Table 4 Antimicrobial susceptibility of Gram-positive bacteria from DNF patients (%)
Antibiotics | Staphyloco-ccus aureus (n = 20) | Enterococcus faecalis (n = 18) | Streptococcus agalactiae (n = 11) | Streptococcus dysgalactiae (n = 6) | Streptococcu-s anginosus (n = 5) | Enterococ-cus avium (n = 3) | Enterococcus gallinarum (n = 1) | Enterococcus raffinosus (n = 1) |
|---|---|---|---|---|---|---|---|---|
Gentamicin | 85.0% | 55.6% | – | – | – | 66.7% | 0.0% | 100.0% |
Streptomycin | – | 75.0% | – | – | – | 100.0% | 0.0% | 100.0% |
Ampicillin | – | 94.4% | 100.0% | – | – | 33.3% | 0.0% | 0.0% |
Levofloxacin | 90.0% | 88.9% | 63.6% | 100.0% | 100.0% | 100.0% | 0.0% | 100.0% |
Moxifloxacin | 90.0% | 88.9% | 72.7% | – | – | 100.0% | 0.0% | 100.0% |
Ciprofloxacin | 82.4% | 68.7% | 66.7% | – | – | 100.0% | 0.0% | 100.0% |
Clindamycin | 35.0% | 0.0% | 22.2% | 33.3% | 25.0% | 0.0% | 0.0% | 0.0% |
Erythrocin | 35.0% | 5.6% | 16.7% | 33.3% | 25.0% | 66.7% | 0.0% | 100.0% |
Macrodantin | 100.0% | 100.0% | 100.0% | – | – | – | 0.0% | – |
Penicillin G | 5.0% | 94.4% | 100.0% | 100.0% | 100.0% | 66.7% | 0.0% | 0.0% |
Oxacillin | 75.0% | – | – | – | – | – | – | – |
Quinupristin/Dalfopristin | 100.0% | 0.0% | 100.0% | 100.0% | 100.0% | 50.0% | 0.0% | 0.0% |
Rifampicin | 90.0% | – | – | – | – | – | – | – |
Sulfamethox-azole | 100.0% | 0.0% | – | – | – | 0.00% | – | – |
Tetracycline | 64.7% | 12.5% | 22.2% | 50.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Teicoplanin | 100.0% | 100.0% | – | – | – | 100.0% | – | – |
Tigecycline | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% |
Vancomycin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Linezolid | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Chloramphe-nicol | – | – | – | 100.0% | 100.0% | – | – | – |
Cefotaxime | – | – | – | 100.0% | 100.0% | – | – | – |
Daptomycin | 100.0% | 100.0% | 100.0% | – | – | – | – | – |
Ceftaroline | 100.0% | – | – | – | – | – | – | – |